Teleflex Incorporated's Revenue in the fiscal year 2025 $ 1,991.75 millions
Teleflex Incorporated's Revenue in the fiscal year 2024 $ 3,046.68 millions
Teleflex Incorporated's Revenue in the fiscal year 2023 $ 2,973.93 millions
Teleflex Incorporated's Revenue in the fiscal year 2022 $ 2,791.04 millions
Teleflex Incorporated's Revenue in the fiscal year 2021 $ 2,809.56 millions
TFX Revenue third quarter 2026 Y/Y Growth Comment
Teleflex Incorporated reported fall in Revenue in the third quarter 2026 by -37.79% to $ 567.78 millions, from the same quarter in 2025. The drop in the third quarter 2026 Teleflex Incorporated's Revenue compares unfavorably to the Company's average Revenue growth of 3.99%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 172 other companies have achieved higher Revenue growth. While Teleflex Incorporated' s Revenue drop of -37.79% ranks overall at the positon no. 3633 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Teleflex Incorporated's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
16.99 %
1.89 %
-15.78 %
(Sep 28 2025)
TFX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Teleflex Incorporated disclosed decrease in Revenue from the second quarter by -0.45% to $ 567.78 millions, from $ 570.33 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Teleflex Incorporated's Revenue growth quarter on quarter, overall rank is 1214.
In the III. Quarter 2026 Teleflex Incorporated disclosed decrease in Revenue from the second quarter by -0.45% to $ 567.78 millions, from $ 570.33 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Teleflex Incorporated's Revenue growth quarter on quarter, overall rank is 1214.
Teleflex Incorporated's 12 Months Revenue Growth Year on Year
Teleflex Incorporated's cumulative 12 months Revenue continue to drop, but on the faster rate at -59.75% year on year, at Sep 30 2026 compare to the -46.44% decrease at Jun 30 2026. If the Teleflex Incorporated's fiscal year would end at Sep 30 2026, annual Revenue would be $1,284 millions.
In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2465 to 2496.
Teleflex Incorporated's cumulative 12 months Revenue continue to drop, but on the faster rate at -59.75% year on year, at Sep 30 2026 compare to the -46.44% decrease at Jun 30 2026. If the Teleflex Incorporated's fiscal year would end at Sep 30 2026, annual Revenue would be $1,284 millions.
In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2465 to 2496.
About Teleflex Incorporated Revenue Growth Rates (TFX), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
